PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+53.73%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$26.3M
(+25%)
Cap. Flow
-$8.45M
Cap. Flow
% of AUM
-6.35%
Top 10 Holdings %
Top 10 Hldgs %
52.22%
Holding
90
New
4
Increased
8
Reduced
47
Closed
11
Avg Time Held
5.6
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Creative Realities
CREX
|
+$1.13M |
| 2 |
VIDA Global Inc
VIDA
|
+$971K |
| 3 |
QT Imaging Holdings
QTI
|
+$556K |
| 4 |
Crexendo
CXDO
|
+$141K |
| 5 |
Perion Network
PERI
|
+$79.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inogen
INGN
|
+$1.23M |
| 2 |
QuickLogic
QUIK
|
+$856K |
| 3 |
Axogen
AXGN
|
+$847K |
| 4 |
Natera
NTRA
|
+$788K |
| 5 |
CPS Technologies
CPSH
|
+$750K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.3% |
| 2 | Technology | 28.21% |
| 3 | Communication Services | 9.68% |
| 4 | Industrials | 4.29% |
| 5 | Consumer Staples | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
SOPHiA GENETICS
SOPH
$601M
| $60.6K | 0.05% |
10,500
| – | – |
2025 Q4
2 quarters
|
|
77
Pulmonx
LUNG
$76.4M
| $51.4K | 0.04% |
39,500
-1,500
| -4% | -$2.07K |
2025 Q2
4 quarters
|
|
78
Dyadic International
DYAI
$16.4M
| $43.1K | 0.03% |
48,050
| – | – |
2019 Q2
28 quarters
|
|
79
Accuray
ARAY
$20.9M
| $5.16K | ﹤0.01% |
20,000
-32,500
| -62% | -$12.1K |
2022 Q2
16 quarters
|
|
80
ANI Pharmaceuticals
ANIP
$1.61B
| – | – |
-7,841
| Closed | -$603K | – |
|
81
Asure Software
ASUR
$207M
| – | – |
-23,500
| Closed | -$202K | – |
|
82
DELISTED
BioLife Solutions
BLFS
| – | – |
-12,500
| Closed | -$239K | – |
|
|
83
CPS Technologies
CPSH
$68.2M
| – | – |
-200,585
| Closed | -$750K | – |
|
84
Digi International
DGII
$2.71B
| – | – |
-7,333
| Closed | -$353K | – |
|
|
85
Inogen
INGN
$163M
| – | – |
-199,600
| Closed | -$1.23M | – |
|
86
ePlus
PLUS
$2.47B
| – | – |
-5,000
| Closed | -$376K | – |
|
87
Rockwell Medical
RMTI
$30.9M
| – | – |
-7,037
| Closed | -$62.9K | – |
|
88
Vericel Corp
VCEL
$2.06B
| – | – |
-10,450
| Closed | -$336K | – |
|
89
Veritone
VERI
$53.8M
| – | – |
-157,250
| Closed | -$310K | – |
|
90
ExxonMobil
XOM
$728B
| – | – |
-1,194
| Closed | -$203K | – |
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Perkins Capital Management held 90 positions worth $133M, up 25% from $107M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Perkins Capital Management withdrew a net $8.45M in Q2 2026, closing 11 positions and reducing 47 holdings. Its most notable exit was Inogen, an estimated $1.23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in Creative Realities worth $1.24M.
- Perkins Capital Management's largest Q2 2026 buy was Creative Realities: 300,050 shares worth $1.24M.
- Perkins Capital Management added most to Crexendo in Q2 2026, an estimated $141K increase.
- Perkins Capital Management's biggest Q2 2026 reduction was QuickLogic, cutting an estimated $856K.
- Perkins Capital Management fully exited Inogen in Q2 2026, selling an estimated $1.23M.
- Perkins Capital Management's ten largest holdings make up 52% of its $133M portfolio in Q2 2026.
- Perkins Capital Management opened 4 new positions and closed 11 in Q2 2026.
- Perkins Capital Management's portfolio value rose 25% quarter-over-quarter to $133M.
Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.